Advertisement

Fasting Serum Triglyceride and Cholesterol Levels During Oral Contraceptive Therapy

  • V. Wynn
  • J. W. H. Doar

Abstract

We have previously found elevated serum triglyceride, cholesterol, and low density and very low density lipoprotein levels in a cross-sectional study of 102 women receiving oral contraceptive therapy (1). While changes of serum triglyceride levels were marked, only slight elevations of serum cholesterol levels were observed.

Keywords

Serum Lipid Serum Triglyceride Serum Cholesterol Level Fasting Serum Serum Lipid Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wynn, V., Doar, J.W.H. and Mills, G.L.: Some effects of oral contraceptives on serum-lipid and lipoprotein levels. The Lancet 1:720 (1966).CrossRefGoogle Scholar
  2. 2.
    De Lalla, O.F., Gofman, J.W. in Methods of Biochemical Analysis (edited by D. Glick). Vol. 1, p. 459 (1954), New York.CrossRefGoogle Scholar
  3. 3.
    Kannel, W.B., Kagan, A., Revotskie, N. and Stokes, J.: Factors of risk in the development of coronary heart disease. The Framingham study. Ann. Intern. Med. 55:33 (1961).PubMedGoogle Scholar
  4. 4.
    Aurell, M., Cramer, K. and Rybo, G.: Serum lipids and lipoproteins during long-term administration of an oral contraceptive. The Lancet 1:291 (1966).CrossRefGoogle Scholar
  5. 5.
    Brody, S., Kerstell, J., Nilsson, L. and Svanborg, A.: The effects of some ovulation inhibitors on the different plasma lipid fractions. Acta Medica Scand. 183:1 (1968).CrossRefGoogle Scholar
  6. 6.
    Gershberg, H., Hülse, M. and Javier, Z.: Hypertriglyceridemia during treatment with estrogen and oral contraceptives: an alteration in hepatic function? Obst, and Gyn. 31:186 (1968).CrossRefGoogle Scholar
  7. 7.
    Hazzard, W.R., Spiger, M.J., Bagdade, J.D. and Bierman, E.L.: Mechanisms for hypertriglyceridemia induced by oral contraceptives. Excerpta Medica International Congress Series No. 157, 39 (1968).Google Scholar
  8. 8.
    Stoker, D.J., Wynn, V. and Robertson, G.: Effect of posture on plasma cholesterol level. Br. Med. J. 1:336 (1966).PubMedCrossRefGoogle Scholar
  9. 9.
    Zlatkis, A., Zak, B. and Boyle, A.J.: New method for the determination of serum cholesterol. J. Lab. Clin. Med. 41:486 (1953).PubMedGoogle Scholar
  10. 10.
    Henly, A.A.: The determination of seriim cholesterol. Analyst Lond. 82:286 (1957).Google Scholar
  11. 11.
    Cramp, D.G. and Robertson, G.: The fluorometric assay of triglyceride by a semi-automated method. Anal. Biochem. (In press).Google Scholar
  12. 12.
    Furman, R.H., Howard, R.P., Norcia, L.N. and Keaty, E.G.: The influence of androgens, estrogens and related steroids on serum lipids and lipoproteins. Am. J. Med. 24:80 (1958).PubMedCrossRefGoogle Scholar
  13. 13.
    Robinson, R.W. and Lebeau, R.J.; Effect of conjugated equine estrogens on serum lipids and the clotting mechanism. J. Atheroscler. Res. 5:120 (1965).PubMedCrossRefGoogle Scholar
  14. 14.
    Svanborg, A. and Vikrot, O.: The effect of estradiol and progesterone on plasma lipids in oophorectomized women. Acta Medica Scand. 179:615 (1966).CrossRefGoogle Scholar
  15. 15.
    Hood, B. and Cramer, K.: Effects on serum lipoprotein cholesterol of estrogen in combination with A4 - androstenedione, testosterone and methyltestosterone. Acta Med. Scand. 165;459–466 (1959).PubMedCrossRefGoogle Scholar
  16. 16.
    Pincus, G. in Control of Fertility, p. 277 (1965) New York.Google Scholar
  17. 17.
    Havel, R.J.: Metabolism of lipids in chylomicrons and very low density lipoproteins. In Handbook of Physiology, Section 5: Adipose tissue. Edited by A.E. Renold and G.F. Cahill, Jr. p. 499 (1965). Waverly Press Inc., Baltimore.Google Scholar
  18. 18.
    Doe, R.P., Meilinger, G.T., Swaim, W.R. and Seal, U.S.: Estrogen dosage effects on serum proteins: a longitudinal study, J. Clin. Endocr. 27:1081 (1967).PubMedCrossRefGoogle Scholar
  19. 19.
    Furman, R.H., Alaupovic, P., Bradford, R.H. and Howard, R.P.: Gonadal hormones, blood lipids and ischemic heart disease. International Symposium on Recent Advances in Atherosclerosis, Athens (1966), p. 20.Google Scholar
  20. 20.
    Kannel, W.B., Dawber, T.R., Friedman, G.D., Glennon, W.E. and McNamara, P.M.: Risks in coronary heart disease. Ann. Intern, Med. 61:888 (1964).Google Scholar

Copyright information

© Plenum Press, New York 1969

Authors and Affiliations

  • V. Wynn
    • 1
  • J. W. H. Doar
    • 1
  1. 1.Alexander Simpson Laboratory for Metabolic ResearchSt. Mary’s Hospital Medical SchoolLondonUK

Personalised recommendations